Singapore, Singapore · Founded 2022 · Privately Held (backing)
Developer of antibody-drug conjugate therapies designed for treating cancer. Axcynsis Therapeutics is based in Singapore, Singapore and was founded in 2022. Its last known valuation is $36.1 million. It has raised $21 million.
Last price · $/share
—
Implied valuation
$36.1M
Total raised
$21.0M
Last round
—
Team — not yet on record
No current team members for Axcynsis Therapeutics are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Axcynsis Therapeutics with a free account
·Watch Axcynsis Therapeutics: the Monday email on marks, rounds and moves
